SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.86−0.17 (-2.12%)
Close on Nov 13, 2026Market cap $1.59BP/E –Yield –
SELLAS Life Sciences operating margin
Operating margin is operating income as a percentage of revenue.
SELLAS Life Sciences's operating margin for the twelve months ending Dec 31, 2022 was -4195.0%. For fiscal 2022 it was -4195.0%, against -332.8% the year before. The highest annual figure on record is -332.8% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -4195.0% | −3862.2 |
| FY2021 | Dec 31, 2021 | -332.8% | +561.0 |
| FY2020 | Dec 31, 2020 | -893.8% | −422.7 |
| FY2014 | Dec 31, 2014 | -471.1% | +674.4 |
| FY2013 | Dec 31, 2013 | -1145.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2022 | Mar 31, 2022 | -1673.5% | – |
| Q2 FY2021 | Jun 30, 2021 | -234.4% | – |
| Q1 FY2021 | Mar 31, 2021 | -39.4% | – |
| Q4 FY2020 | Dec 31, 2020 | -218.9% | – |
See a number that looks wrong?